Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Background: Many clinical trials have been conducted to verify the effects of interventions for prevention of type 2 diabetes (T2D) using different treatments and outcomes. The aim of this study was to compare the effectiveness of lifestyle modifications (LM) with other treatments in persons at high risk of T2D by a network meta-analysis (NMA). Methods: Searches were performed of PUBMED up to January 2018 to identify randomized controlled trials. The odds ratio (OR) with onset of T2D at 1 year in the intervention group (LM, dietary, exercise, or medication) versus a control group (standard treatments or placebo) were the effect sizes. Frequentist and Bayesian NMAs were conducted. Results: Forty-seven interventions and 12 treatments (20,113 participants) were used for the analyses. The OR in the LM was approximately 0.46 (95% CI: 0.33 to 0.61) times lower compared to the standard intervention by the Bayesian approach. The effects of LM compared to other treatments by indirect comparisons were not significant. Conclusions: This meta-analysis further strengthened the evidence that LM reduces the onset of T2D compared to standard and placebo interventions and appears to be at least as effective as nine other treatments in preventing T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“At the core of CMD is the insulin-resistant state characterized by a glucoregulatory defect (ie, normal or elevated glycemia in the face of hyperinsulinemia) accompanied by multiple biochemical abnormalities involving molecular signaling, gene expression, oxidative stress, mitochondrial dysfunction, and accumulation of inflammatory macrophages in adipose tissue that alters release of adipocyt”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [808]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“As for the risk of bias across studies, publication bias was examined by funnel plot and, when necessary, we conducted sensitivity analyses to adjust for it using the trim and fill method [17,18].”
MethodHutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269 · cited 1×
“Studies were selected by following PRISMA guidelines [20].”
MethodPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473905 · Cited by 2,955
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
Higgins, J. P. T., Jackson, D., Barrett, J. K., Lu, G., Ades, A. E., & White, I. R. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1044 · Cited by 2,098 · cited 1×
“Evidence of inconsistency was tested using the global test for inconsistency based on the design-by-treatment inconsistency model [16].”
MethodXENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915 · cited 1×
“The subgroup was treated as an independent study in three studies [32,38,54].”
ResultRamachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
White, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1288 · Cited by 901 · cited 1×
“In most trials, the control diet and exercise were the subjects’ usual ones, while lifestyle education included some special diets such as the Mediterranean diet [52] among others.”
BackgroundAune, D., Norat, T., Leitzmann, M., Tonstad, S., & Vatten, L. J. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0056-z · Cited by 880
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737 · cited 2×
“included patients with overweight or obesity and six trials [25,41,51,54,58,59] not only included those with IGT but also with IGT or IFG.”
BackgroundEnvironmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
Kolb, H., & Martin, S. (2017) · BMC Medicine · doi:10.1186/s12916-017-0901-x · Cited by 717
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
Kosaka, K., Noda, M., & Kuzuya, T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.010 · Cited by 656
Chiavaroli, L., Viguiliouk, E., Nishi, S., Blanco Mejia, S., Rahelić, D., Kahleová, H., Salas-Salvadó, J., Kendall, C., & Sievenpiper, J. (2019) · Nutrients · doi:10.3390/nu11020338 · Cited by 548 · cited 1×
“In both cases, in the real world more research on diabetes-protective mechanisms [62] as well as the cost of treatments seems warranted.”
BackgroundEffects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis
Yamaoka, K., & Tango, T. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-138 · Cited by 407
Self-citationMultivariate Random-effects Meta-regression: Updates to Mvmeta
White, I. R. (2011) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1101100206 · Cited by 400
Network meta-analysis-highly attractive but more methodological research is needed
Li, T., Puhan, M. A., Vedula, S. S., Singh, S., Dickersin, K., & The Ad Hoc Network Meta-analysis Methods Meeting Working Group (2011) · BMC Medicine · doi:10.1186/1741-7015-9-79 · Cited by 361
Heymsfield, S. B., Segal, K. R., Hauptman, J., Lucas, C. P., Boldrin, M. N., Rissanen, A., Wilding, J. P. H., & Sjöström, L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1321 · Cited by 358
Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316 · cited 1×
“By consulting meta-analyses for diet and physical interventions in the Cochran review [60], when the trials were classified into two subgroups according to duration of 4 years or more or less than 4 years, relatively similar RRs were obtained (0.”
MethodKawamori, R., Tajima, N., Iwamoto, Y., Kashiwagi, A., Shimamoto, K., & Kaku, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60222-1 · Cited by 303
Galaviz, K. I., Weber, M. B., Straus, A., Haw, J. S., Narayan, K. M. V., & Ali, M. K. (2018) · Diabetes Care · doi:10.2337/dc17-2222 · Cited by 289 · cited 1×
“Furthermore, a recent umbrella review examined the effect of the consumption of a Dietary Approaches to Stop Hypertension (DASH) dietary pattern and diabetes incidence as one of the cardiometabolic outcomes [61] and the authors concluded that the relationship remained uncertain and that future studies would likely have”
BackgroundSaito, T. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.275 · Cited by 277
Efficacy of Lifestyle Education to Prevent Type 2 Diabetes
Yamaoka, K., & Tango, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2780 · Cited by 269
Self-citationRiley, R. D., Jackson, D., Salanti, G., Burke, D. L., Price, M., Kirkham, J., & White, I. R. (2017) · BMJ · doi:10.1136/bmj.j3932 · Cited by 247
Zinman, B., Harris, S. B., Neuman, J., Gerstein, H. C., Retnakaran, R. R., Raboud, J., Qi, Y., & Hanley, A. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60746-5 · Cited by 235
Yates, T., Davies, M., Gorely, T., Bull, F., & Khunti, K. (2009) · Diabetes Care · doi:10.2337/dc09-0130 · Cited by 219
Ockene, I. S., Tellez, T. L., Rosal, M. C., Reed, G. W., Mordes, J., Merriam, P. A., Olendzki, B. C., Handelman, G., Nicolosi, R., & Ma, Y. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300357 · Cited by 201
The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial
Weber, M. B., Ranjani, H., Staimez, L. R., Anjana, R. M., Ali, M. K., Narayan, K. M. V., & Mohan, V. (2016) · Diabetes Care · doi:10.2337/dc16-1241 · Cited by 189
Impact of 3‐year lifestyle intervention on postprandial glucose metabolism: the SLIM study
Roumen, C., Corpeleijn, E., Feskens, E. J. M., Mensink, M., Saris, W. H. M., & Blaak, E. E. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02417.x · Cited by 187
Dungan, J. S. (2011) · Yearbook of Obstetrics, Gynecology and Women's Health · doi:10.1016/j.yobg.2011.05.175 · Cited by 173
Penn, L., White, M. J., Oldroyd, J. C., Walker, M., Alberti, K. G. M. M., & Mathers, J. C. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-342 · Cited by 158
Japan Diabetes Prevention Program (JDPP) Research Group the for, Sakane, N., Sato, J., Tsushita, K., Tsujii, S., Kotani, K., Tsuzaki, K., Tominaga, M., Kawazu, S., Sato, Y., et al. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-40 · Cited by 126
The National Diabetes Prevention Program
Robitscher, J. W. (2020) · Cited by 110
Ramachandran, A., Snehalatha, C., Mary, S., Selvam, S., Kumar, C. K. S., Seeli, A. C., & Shetty, A. S. (2009) · Diabetologia · doi:10.1007/s00125-009-1315-x · Cited by 105
Effect of metformin on patients with impaired glucose tolerance
Li, C. L., Pan, C., Lu, J., Zhu, Y., Wang, J. H., Deng, X., Xia, F., Wang, H. Z., & Wang, H. Y. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00090.x · Cited by 98
Wong, C. K. H., Fung, C. S. C., Siu, S. C., Lo, Y. Y. C., Wong, K., Fong, D., & Lam, C. L. K. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.002 · Cited by 95
Wein, P., Beischer, N., Harris, C., & Permezel, M. (1999) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1999.tb03363.x · Cited by 94
Liao, D., Asberry, P. J., Shofer, J. B., Callahan, H. S., Matthys, C. C., Boyko, E. J., Leonetti, D. L., Kahn, S. E., Austin, M. A., Newell, L., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1504 · Cited by 94
Lian, F., Li, G., Chen, X., Wang, X., Piao, C., Wang, J., Hong, Y., Ba, Z., Wu, S., Zhou, X., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3276 · Cited by 89
Oldroyd, J. C., Unwin, N. C., White, M. J., Imrie, K., Mathers, J. C., & Alberti, K. G. M. M. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00244-8 · Cited by 84
Watanabe, M., Yamaoka, K., Yokotsuka, M., & Tango, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3209 · Cited by 69
Self-citationVermunt, P. W. A., Milder, I. E. J., Wielaard, F., de Vries, J. H. M., Baan, C. A., van Oers, J. A. M., & Westert, G. P. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03648.x · Cited by 51
Kawahara, T., Takahashi, K., Inazu, T., Arao, T., Kawahara, C., Tabata, T., Moriyama, H., Okada, Y., Morita, E., & Tanaka, Y. (2008) · Diabetes Care · doi:10.2337/dc07-2272 · Cited by 48
Xu, D.-F., Sun, J.-Q., Chen, M., Chen, Y.-Q., Xie, H., Sun, W.-J., Lin, Y.-F., Jiang, J.-J., Sun, W., Chen, A.-F., et al. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512001328 · Cited by 44
Gagnon, C., Brown, C., Couture, C., Kamga-Ngandé, C., Hivert, M., Baillargeon, J., Carpentier, A. C., & Langlois, M. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.01.003 · Cited by 41
Nutritional supplements for the prevention of diabetes mellitus and its complications
Yeung, S., Soliternik, J., & Mazzola, N. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.07.003 · Cited by 31
Fang, Z., Zhao, J., Shi, G.-B., Shu, Y., Ni, Y., Wang, H., Ding, L., Lu, R., Li, J., Xiaojin, Z., et al. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.08.004 · Cited by 30
ERIKSSON, J. G., LEHTOVIRTA, M., EHRNSTRÖM, B., SALMELA, S., & GROOP, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01633.x · Cited by 29
Lu, Y., Lu, J., Wang, S., Li, C., Zheng, R.-P., Tian, H., & Wang, X. (2011) · Advances in Therapy · doi:10.1007/s12325-011-0022-4 · Cited by 28
Pang, B., Zhang, Y., Liu, J., He, L., Zheng, Y., Lian, F., & Tong, X. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0316-x · Cited by 13
Fan, G., Luo, G., Mei-lin, Q., Li, S., Ai-hua, T., & Xian-yu, T. (2004) · Chinese Journal of Integrative Medicine · doi:10.1007/bf02836384 · Cited by 10
Zhou, J. (2011) · PubMed · Cited by 5
Research works printed but not linked: 2
- Tao, 2004, Effect of exercise training in patients with impaired glucose tolerance, Chin. J. Clin. Rehabil., 8, 2912
- Odawara, 2013, Effect of pitavastatin on the incidence of diabetes in Japanese individuals with impaired glucose tolerance, Diabetologia, 56, S59
Cited by
Cai, X., Zhang, Y., Li, M., Wu, J. H., Mai, L., Li, J., Yang, Y., Hu, Y., & Huang, Y. (2020) · BMJ · doi:10.1136/bmj.m2297 · Cited by 749
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Healthy Eating and Active Lifestyles: Best Practices in Public Health
OECD (2022) · OECD eBooks · doi:10.1787/40f65568-en · Cited by 276
Toi, P. L., Anothaisintawee, T., Chaikledkaew, U., Briones, J. R., Reutrakul, S., & Thakkinstian, A. (2020) · Nutrients · doi:10.3390/nu12092722 · Cited by 178
Healthy Aging—Nutrition Matters: Start Early and Screen Often
Roberts, S. B., Silver, R. E., Das, S. K., Fielding, R. A., Gilhooly, C. H., Jacques, P. F., Kelly, J. M., Mason, J. B., McKeown, N. M., Reardon, M. A., et al. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab032 · Cited by 152
Metadata
- Authors
- Yamaoka, K., Nemoto, A., & Tango, T.
- Affiliations
- Teikyo University (JP)
- Corresponding author
- Yamaoka, Kazue
- ORCID
- Yamaoka, Kazue
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-06-19
- Volume
- 11
- Issue
- 6
- Pages
- 1373
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6627198
- OpenAlex
- W2951082906
- Cited by
- 32
- References
- 63
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 4
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Centers for Disease Control and Prevention
- Japan Society for the Promotion of Science (18K11064, 17K09213, 17K00936, 17K00057)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- type 2 diabetes prevention, lifestyle modification, vulnerable populations, dietary intervention, exercise intervention, antidiabetic drugs, indirect comparison
- MeSH terms
- Healthy Lifestyle, Diet, Healthy, Hypolipidemic Agents, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Risk Factors, Exercise, Incidence, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Assessment, Risk Reduction Behavior, Protective Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.